<SEC-DOCUMENT>0001209191-23-055721.txt : 20231117
<SEC-HEADER>0001209191-23-055721.hdr.sgml : 20231117
<ACCEPTANCE-DATETIME>20231117161041
ACCESSION NUMBER:		0001209191-23-055721
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20231115
FILED AS OF DATE:		20231117
DATE AS OF CHANGE:		20231117

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Couling John D
		CENTRAL INDEX KEY:			0001894052

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32431
		FILM NUMBER:		231418759

	MAIL ADDRESS:	
		STREET 1:		C/O DOLBY LABORATORIES, INC.
		STREET 2:		1275 MARKET STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94103

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Dolby Laboratories, Inc.
		CENTRAL INDEX KEY:			0001308547
		STANDARD INDUSTRIAL CLASSIFICATION:	PATENT OWNERS & LESSORS [6794]
		IRS NUMBER:				900199783
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0927

	BUSINESS ADDRESS:	
		STREET 1:		1275 MARKET STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94103
		BUSINESS PHONE:		415 558 0200

	MAIL ADDRESS:	
		STREET 1:		1275 MARKET STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94103
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0508</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2023-11-15</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001308547</issuerCik>
        <issuerName>Dolby Laboratories, Inc.</issuerName>
        <issuerTradingSymbol>DLB</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001894052</rptOwnerCik>
            <rptOwnerName>Couling John D</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O DOLBY LABORATORIES, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>1275 MARKET STREET</rptOwnerStreet2>
            <rptOwnerCity>SAN FRANCISCO</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>94103</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>SVP, Entertainment</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>0</aff10b5One>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Class A Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2023-11-15</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>S</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>79</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>88.58</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>96370</value>
                    <footnoteId id="F1"/>
                    <footnoteId id="F2"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">Shares held following the reported transaction include 43,636 restricted stock units, which are subject to forfeiture until they vest.</footnote>
        <footnote id="F2">Shares include (1) 87 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2021, (2) 38 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2022, and (3) 79 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2023.  The shares acquired on November 15, 2021 and November 15, 2022 were not included in share totals reported previously due to administrative error.</footnote>
    </footnotes>

    <remarks>The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 17, 2022, as amended February 6, 2023, which was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) in effect at the time of adoption.</remarks>

    <ownerSignature>
        <signatureName>/s/ Daniel Rodriguez, Attorney-in-Fact for John Couling</signatureName>
        <signatureDate>2023-11-17</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
